Literature DB >> 16521222

Cyclooxygenase-2 and epithelial growth factor receptor up-regulation during progression of Barrett's esophagus to adenocarcinoma.

Yan Li1, John M Wo, Mukunda B Ray, Whitney Jones, Ruifeng R Su, Susan Ellis, Robert C G Martin.   

Abstract

AIM: To investigate the expression of cyclooxygenase-2 (COX-2) and epithelial growth factor receptor (EGFR) throughout the progression of Barretts esophagus (BE).
METHODS: COX-2 and EGFR protein expressions were detected by using immunohistochemical method. A detailed cytomorphological changes were determined. Areas of COX-2 and EGFR expression were quantified by using computer Imaging System.
RESULTS: The expressions of both COX-2 and EGFR increased along with the progression from BE to esophagus adenocarcinoma (EAC). A positive correlation was found between COX-2 expression and EGFR expression.
CONCLUSION: COX-2 and EGFR may be cooperative in the stepwise progression from BE to EAC, thereby leading to carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16521222      PMCID: PMC4066159          DOI: 10.3748/wjg.v12.i6.928

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  38 in total

Review 1.  Epidemiology and molecular biology of Barrett's adenocarcinoma.

Authors:  N K Altorki; S Oliveria; D S Schrump
Journal:  Semin Surg Oncol       Date:  1997 Jul-Aug

2.  Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway.

Authors:  R Hanif; A Pittas; Y Feng; M I Koutsos; L Qiao; L Staiano-Coico; S I Shiff; B Rigas
Journal:  Biochem Pharmacol       Date:  1996-07-26       Impact factor: 5.858

3.  Cyclooxygenase-2 expression in human esophageal carcinoma.

Authors:  K C Zimmermann; M Sarbia; A A Weber; F Borchard; H E Gabbert; K Schrör
Journal:  Cancer Res       Date:  1999-01-01       Impact factor: 12.701

Review 4.  Cyclooxygenases 1 and 2.

Authors:  J R Vane; Y S Bakhle; R M Botting
Journal:  Annu Rev Pharmacol Toxicol       Date:  1998       Impact factor: 13.820

5.  Natural course of gastroesophageal reflux disease: 17-22 year follow-up of 60 patients.

Authors:  J Isolauri; M Luostarinen; E Isolauri; P Reinikainen; M Viljakka; O Keyriläinen
Journal:  Am J Gastroenterol       Date:  1997-01       Impact factor: 10.864

6.  Strain-dependent epithelial defects in mice lacking the EGF receptor.

Authors:  M Sibilia; E F Wagner
Journal:  Science       Date:  1995-07-14       Impact factor: 47.728

7.  Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse.

Authors:  S G Morham; R Langenbach; C D Loftin; H F Tiano; N Vouloumanos; J C Jennette; J F Mahler; K D Kluckman; A Ledford; C A Lee; O Smithies
Journal:  Cell       Date:  1995-11-03       Impact factor: 41.582

8.  The anti-proliferative effect of sulindac and sulindac sulfide on HT-29 colon cancer cells: alterations in tumor suppressor and cell cycle-regulatory proteins.

Authors:  Y Goldberg; I I Nassif; A Pittas; L L Tsai; B D Dynlacht; B Rigas; S J Shiff
Journal:  Oncogene       Date:  1996-02-15       Impact factor: 9.867

9.  Aspirin and reduced risk of esophageal carcinoma.

Authors:  E M Funkhouser; G B Sharp
Journal:  Cancer       Date:  1995-10-01       Impact factor: 6.860

10.  Determinants of survival following the diagnosis of esophageal adenocarcinoma (United States).

Authors:  D C Farrow; T L Vaughan
Journal:  Cancer Causes Control       Date:  1996-05       Impact factor: 2.506

View more
  14 in total

1.  Biomarkers in exploring the frontiers of diagnosis, prognosis, and therapy of Barrett's esophagus.

Authors:  Patrick Yachimski; Richard M Peek
Journal:  Cancer Prev Res (Phila)       Date:  2011-06

2.  Epidermal growth factor A61G gene polymorphism, gastroesophageal reflux disease and esophageal adenocarcinoma risk.

Authors:  Winson Y Cheung; Rihong Zhai; Matthew H Kulke; Rebecca S Heist; Kofi Asomaning; Clement Ma; Zhaoxi Wang; Li Su; Michael Lanuti; Kenneth K Tanabe; David C Christiani; Geoffrey Liu
Journal:  Carcinogenesis       Date:  2009-06-11       Impact factor: 4.944

3.  Synthesis and characterization of anti-EGFR fluorescent nanoparticles for optical molecular imaging.

Authors:  Leslie W Chan; Yak-Nam Wang; Lih Y Lin; Melissa P Upton; Joo Ha Hwang; Suzie H Pun
Journal:  Bioconjug Chem       Date:  2013-01-10       Impact factor: 4.774

4.  Increase of epidermal growth factor receptor expression in progression of GERD, Barrett, and adenocarcinoma of esophagus.

Authors:  Guilherme Pretto; Richard Ricachenevsky Gurski; Marcelo Binato; Daniel Navarini; Wolfgan William Schmidt Aguiar; Luise Meurer
Journal:  Dig Dis Sci       Date:  2012-08-09       Impact factor: 3.199

Review 5.  Role of nitric oxide in the pathogenesis of Barrett's-associated carcinogenesis.

Authors:  Gen Kusaka; Kaname Uno; Katsunori Iijima; Tooru Shimosegawa
Journal:  World J Gastrointest Pathophysiol       Date:  2016-02-15

Review 6.  Point-Counterpoint: Screening and Surveillance for Barrett's Esophagus, Is It Worthwhile?

Authors:  Fouad Otaki; Prasad G Iyer
Journal:  Dig Dis Sci       Date:  2018-08       Impact factor: 3.199

7.  Characterization of squamous esophageal cells resistant to bile acids at acidic pH: implication for Barrett's esophagus pathogenesis.

Authors:  Aaron Goldman; Hwu Dau Rw Chen; Heather B Roesly; Kimberly A Hill; Margaret E Tome; Bohuslav Dvorak; Harris Bernstein; Katerina Dvorak
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-12-02       Impact factor: 4.052

8.  Toll-like receptor 4 activation in Barrett's esophagus results in a strong increase in COX-2 expression.

Authors:  Romy E Verbeek; Peter D Siersema; Fiebo J Ten Kate; Kees Fluiter; Rhonda F Souza; Frank P Vleggaar; Pauline Bus; Jantine W P M van Baal
Journal:  J Gastroenterol       Date:  2013-08-17       Impact factor: 7.527

9.  Role of epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of esophageal carcinoma and the suggested mechanisms of action.

Authors:  Yaping Xu; Liming Sheng; Weimin Mao
Journal:  Oncol Lett       Date:  2012-10-24       Impact factor: 2.967

10.  COX-2/EGFR expression and survival among women with adenocarcinoma of the lung.

Authors:  Alison L Van Dyke; Michele L Cote; Geoffrey M Prysak; Gina B Claeys; Angie S Wenzlaff; Valerie C Murphy; Fulvio Lonardo; Ann G Schwartz
Journal:  Carcinogenesis       Date:  2008-05-02       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.